Amundi Asset Management US’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $9.18M | Buy |
121,581
+13,177
| +12% | +$995K | 0.01% | 861 |
|
|
2020
Q4 | $9.51M | Buy |
108,404
+8,388
| +8% | +$736K | 0.01% | 825 |
|
|
2020
Q3 | $7.61M | Sell |
100,016
-212,995
| -68% | -$16.2M | 0.01% | 786 |
|
|
2020
Q2 | $38.6M | Buy |
313,011
+155,771
| +99% | +$19.2M | 0.05% | 365 |
|
|
2020
Q1 | $13.3M | Sell |
157,240
-412,730
| -72% | -$34.9M | 0.02% | 498 |
|
|
2019
Q4 | $48.2M | Buy |
569,970
+77,914
| +16% | +$6.59M | 0.06% | 322 |
|
|
2019
Q3 | $33.2M | Sell |
492,056
-12,211
| -2% | -$823K | 0.05% | 375 |
|
|
2019
Q2 | $43.2M | Buy |
504,267
+29,906
| +6% | +$2.56M | 0.04% | 355 |
|
|
2019
Q1 | $42.1M | Buy |
474,361
+35,375
| +8% | +$3.14M | 0.06% | 322 |
|
|
2018
Q4 | $37.4K | Sell |
438,986
-90,567
| -17% | -$7.71K | 0.03% | 306 |
|
|
2018
Q3 | $51.4M | Buy |
529,553
+263,011
| +99% | +$25.5M | 0.07% | 279 |
|
|
2018
Q2 | $25.1M | Buy |
266,542
+15,457
| +6% | +$1.46M | 0.04% | 456 |
|
|
2018
Q1 | $20.4M | Buy |
251,085
+62,133
| +33% | +$5.04M | 0.03% | 474 |
|
|
2017
Q4 | $16.8M | Buy |
+188,952
| New | +$16.8M | 0.03% | 522 |
|